Categories AlphaGraphs, Consumer, Earnings
Delta Air Lines reports record passenger traffic for May; stock up 3%
Aviation firm Delta Air Lines (NYSE: DAL) Tuesday published the traffic report for May, with the number of passengers reaching a record high for the month. The highest daily passenger traffic was also recorded last month.
Total system traffic grew 7% to about 21 billion, with domestic flights accounting for nearly two-thirds of the total revenue passenger miles. All the international segments registered growth during the month.
The uptick reflects an expansion in capacity in both the international and domestic divisions. While the Atlantic and Pacific operations witnessed strong improvement in available seat miles – a measure of carrying capacity -there was a modest decline in Latin America. Total capacity grew 5.3% to 24 billion, compared to May 2018.
Load factor, the ratio of aircraft’s lift to its weight, was 87.6% last month, up 1.3 points from a year earlier. A notable increase at home was partially offset by a slight decline in the load factor of international flights.
While the Atlantic and Pacific operations witnessed an improvement in capacity, there was a modest decline in Latin America
Delta’s aircraft fleet carried a total of 18,116,083 passengers last month, which was up 7.6% from last year and represented a record for the month of May.
Last month, Delta reported a 5% increase in revenues for the first quarter, which translated into double-digit growth in earnings to $0.96 per share. The results benefitted from relatively lower fuel expenses. The management expects the performance to improve further this year, aided by the solid business momentum and the recent renewal of a major contract with American Express (AXP).
Delta shares traded up 3% in the early hours of Tuesday, after opening the session higher. The stock lost around 7% in the past six months, despite making a solid recovery from last year’s lows.
Most Popular
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues
Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came
Riding the AI wave, Nvidia looks set to stay on the high-growth path
After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on